Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis-Reference-Cited by-同舟云学术

Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis

Published:2016-09-13 Issue:3 Volume:37 Page:458-465
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Hov Johannes R.¹²³⁴⁵^ORCID,Boberg Kirsten M.¹²³,Taraldsrud Eli²⁵⁶,Vesterhus Mette¹⁷,Boyadzhieva Maria⁸,Solberg Inger Camilla⁹,Schrumpf Erik¹²,Vatn Morten H.²¹⁰,Lie Benedicte A.²⁵⁶,Molberg Øyvind²¹¹,Karlsen Tom H.¹²³⁴⁵

Affiliation:

1. Division of Surgery; Department of Transplantation Medicine, Inflammatory Medicine and Transplantation; Norwegian PSC Research Center; Oslo University Hospital Rikshospitalet; Oslo Norway

2. Faculty of Medicine; Institute of Clinical Medicine; University of Oslo; Oslo Norway

3. Section of Gastroenterology; Division of Surgery; Department of Transplantation Medicine, Inflammatory Medicine and Transplantation; Oslo University Hospital Rikshospitalet; Oslo Norway

4. Division of Surgery, Inflammatory Medicine and Transplantation; Research Institute of Internal Medicine; Oslo University Hospital; Oslo Norway

5. K.G.Jebsen Inflammation Research Centre; Faculty of Medicine; Institute of Clinical Medicine; University of Oslo; Oslo Norway

6. Department of Immunology; Oslo University Hospital Rikshospitalet; Oslo Norway

7. National Centre for Ultrasound in Gastroenterology; Haukeland University Hospital; Bergen Norway

8. Clinical Center of Endocrinology; Medical University Sofia; Sofia Bulgaria

9. Division of Medicine; Department of Gastroenterology; Oslo University Hospital Ullevål; Oslo Norway

10. EpiGen Institute; Campus AHUS; Akershus University Hospital; Nordbyhagen Norway

11. Rheumatology Unit; Oslo University Hospital Rikshospitalet; Oslo Norway

Funder

Norwegian PSC Research Centre

Norges Forskningsråd

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13238/fullpdf

Reference38 articles.

1. Primary sclerosing cholangitis;Hirschfield;Lancet,2013

2. Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis;Saarinen;Am J Gastroenterol,2000

3. Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis;Bergquist;Clin Gastroenterol Hepatol,2008

4. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease;Schrumpf;Scand J Gastroenterol,1982

5. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci;Melum;Nat Genet,2011

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tubulin beta 5 is not the target of antineutrophil antibodies in primary sclerosing cholangitis;Clinical and Experimental Immunology;2024-07-03

2. Linee guida SIPMeL per la determinazione degli autoanticorpi nella diagnosi delle malattie autoimmuni del fegato;La Rivista Italiana della Medicina di Laboratorio;2024-04

3. Primary sclerosing cholangitis and IgG4-associated cholangitis;The Rose and Mackay Textbook of Autoimmune Diseases;2024

4. Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axis;Experimental & Molecular Medicine;2023-07-18

5. Role of microbiome in autoimmune liver diseases;Hepatology;2023-06-27